The Knox County Health Department has laid off seven employees ‒ six full-time and one part-time ‒ after the federal ...
Sponsored by Pfizer - For actress and producer Elizabeth Banks, turning 50 meant prioritizing preventative care to stay ...
EDT Vaxcyte (PCVX) sinks 35% to $45 after pneumococcal disease vaccine resultsDon't Miss Our End of Quarter Offers: Discover the latest ...
Vaxcyte's VAX-24 Phase 2 trial showed a safety profile similar to PCV20, with strong immune responses and no serious ...
1d
Clinical Trials Arena on MSNVaxcyte stock sinks despite Phase II IPD vaccine trial successVaxcyte’s stock has dropped around 45% despite a Phase II trial of its invasive pneumococcal disease (IPD) vaccine meeting ...
Vaxcyte plunges 56% even though its VAX-24 pneumonia vaccine shows positive phase two results in infants. Read more here.
MSD has received approval from the European Commission (EC) for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to prevent invasive disease and pneumonia due to Streptococcus pneumoniae ...
In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new ...
Vaxcyte, Inc.'s positive phase 2 results for VAX-24 show promise in preventing invasive pneumococcal disease in infants.
A lack of vaccination against respiratory pathogens was commonly identified among US international travelers, indicating the need to improve vaccine uptake at pre-travel visits.
At All Doses Evaluated, VAX-24 Was Well-Tolerated and Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20® (PCV20) -- -- At ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results